FSH with Tanner Stages
Test Mnemonic
FSHTAN
CPT Codes
- 83001 - QTY (1)
Aliases
- Follicle Stimulating Hormone
- FSH
Performing Laboratory
Cleveland Clinic Laboratories
Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 1 mL | Plasma | Lithium heparin PST (Lt. Green) | Refrigerated |
Alternate Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 1 mL | Serum | SST (Gold) | Refrigerated |
Minimum Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 0.5 mL |
Stability
| Environmental Condition | Description |
|---|---|
| Ambient | 5 days |
| Refrigerated | 14 days |
| Frozen | Plasma: 6 months. Serum: 12 months |
Days Performed
Sun - Sat
Turnaround Time
1 - 2 days
Methodology
| Name | Description |
|---|---|
| Electro Chemiluminescence Immunoassay (ECLIA) |
Reference Range
| FSH | |||||
|---|---|---|---|---|---|
| Sex | Age From | Age To | Type | Range | Range Unit |
| Female Tanner Stage I: 0.6 - 5.0 mU/mL (Age: < 9.2 years) | Female Tanner Stage II: 0.6 - 8.9 mU/mL (Age: 9 - 13.7 years) | Female Tanner Stage III: 0.6 - 9.0 mU/mL (Age: 10 - 14.4 years) | Female Tanner Stage IV-V: 0.7 - 11.0 mU/mL (Age: 10.7 - 18.6 years) | Male Tanner Stage I: 0.3 - 2.9 mU/mL (Age: < 9.8 years) | Male Tanner Stage II: 0.5 - 4.8 mU/mL (Age: 9.8 - 14 years) | Male Tanner Stage III: 1.0 - 6.4 mU/mL (Age: 10.7 - 15.4 years) | Male Tanner Stage IV-V: 1.0 - 8.1 mU/mL (Age: 11.7 - 17.3 years) |
Special Info
Patients taking a biotin dose of up to 5 mg/day should refrain from taking biotin for 4 hours prior to sample collection. Patients taking a biotin dose of 5 to 10 mg/day should refrain from taking biotin for 8 hours prior to sample collection. Patients taking a biotin dose > 10 mg/day should consult with their physician or the laboratory prior to having a sample taken. Clinicians should consider biotin interference as a source of error, when clinically suspicious of the laboratory result.
Clinical Info
Assessment of pituitary function and to distinguish primary from secondary gonadal failure.